Terms: = Gastric cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Prognosis
21 results:
1. The Use of Antibiotics During Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Advanced Esophagogastric cancer.
Zhang L; Kuang T; Chai D; Deng W; Wang P; Wang W
Int Immunopharmacol; 2023 Jun; 119():110200. PubMed ID: 37099942
[TBL] [Abstract] [Full Text] [Related]
2. Association Between Single Nucleotide Polymorphisms of miRNAs and gastric cancer: A Scoping Review.
Pan L; Shi Y; Zhang J; Luo G
Genet Test Mol Biomarkers; 2022 Oct; 26(10):459-467. PubMed ID: 36251855
[No Abstract] [Full Text] [Related]
3. The Significance of Surgical Intervention for Metasynchronous Liver Metastasis in gastric cancer: A Single-centre Analysis.
Hanaki T; Sunaguchi T; Goto K; Morimoto M; Murakami Y; Shishido Y; Miyatani K; Kihara K; Matsunaga T; Yamamoto M; Tokuyasu N; Sakamoto T; Hasegawa T; Fujiwara Y
Anticancer Res; 2022 Apr; 42(4):2177-2184. PubMed ID: 35347042
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features and prognosis of gastric tube cancer after esophagectomy for esophageal cancer: a nationwide study in Japan.
Ota M; Morita M; Ikebe M; Nakashima Y; Yamamoto M; Matsubara H; Kakeji Y; Doki Y; Toh Y
Esophagus; 2022 Jul; 19(3):384-392. PubMed ID: 35239079
[TBL] [Abstract] [Full Text] [Related]
5. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples.
Jansen K; Farahi N; Büscheck F; Lennartz M; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Jacobsen F; Minner S; Krech R; Clauditz T; Bernreuther C; Dum D; Krech T; Marx A; Steurer S
Pathol Res Pract; 2021 Dec; 228():153663. PubMed ID: 34717148
[TBL] [Abstract] [Full Text] [Related]
6. [The value of spleen density in predicting prognosis of patients with gastric cancer after curative gastrectomy].
Li S; Ma PF; Zhang JL; Cao YH; Liu CY; Zhang XJ; Li ZY; Xue YW; Zhao YZ
Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(34):2703-2709. PubMed ID: 34510877
[No Abstract] [Full Text] [Related]
7. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
Kim J; Han SH; Kim HI
J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
[TBL] [Abstract] [Full Text] [Related]
8. A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care.
Shimozaki K; Nakayama I; Takahari D; Kamiimabeppu D; Osumi H; Wakatsuki T; Ooki A; Ogura M; Shinozaki E; Chin K; Yamaguchi K
ESMO Open; 2021 Oct; 6(5):100234. PubMed ID: 34461485
[TBL] [Abstract] [Full Text] [Related]
9. Constructing a new prognostic signature of gastric cancer based on multiple data sets.
Zhou L; Lu H; Zeng F; Zhou Q; Li S; Wu Y; Yuan Y; Xin L
Bioengineered; 2021 Dec; 12(1):2820-2835. PubMed ID: 34157940
[TBL] [Abstract] [Full Text] [Related]
10. Differences Between Laparoscopic and Open Gastrectomy on the Impact of Postoperative Infectious Complications on prognosis.
Nagata H; Tsujimoto H; Kouzu K; Itazaki Y; Ishibashi Y; Tsuchiya S; Sugihara T; Ito N; Harada M; Nomura S; Kishi Y; Ueno H
Anticancer Res; 2020 Dec; 40(12):7109-7117. PubMed ID: 33288610
[TBL] [Abstract] [Full Text] [Related]
11. The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608.
Miao Z; Guo X; Tian L
Gene; 2019 Mar; 687():116-124. PubMed ID: 30453063
[TBL] [Abstract] [Full Text] [Related]
12. [Analysis of gastric gastrointestinal stromal tumors in Shandong Province: a midterm report of multicenter GISSG1201 study].
Hou Q; Luo W; Li L; Dai Y; Jiang L; Wang A; Chu X; Li Y; Yang D; Lu C; Yao L; Cui G; Lin H; Chen G; Cui Q; Zhang H; Lun Z; Xia L; Su Y; Han G; Hui X; Wei Z; Sun Z; Guo H; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1025-1030. PubMed ID: 28900994
[TBL] [Abstract] [Full Text] [Related]
13. Association of the miR-146a rs2910164 polymorphism with gastric cancer susceptibility and prognosis.
Jiang J; Jia ZF; Cao DH; Wu YH; Sun ZW; Cao XY
Future Oncol; 2016 Oct; 12(19):2215-26. PubMed ID: 27267319
[TBL] [Abstract] [Full Text] [Related]
14. Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.
Chen JH; Cai SR; Zhai ET; Chen SL; Wu KM; Song W; He YL
Int J Clin Exp Pathol; 2015; 8(11):14365-73. PubMed ID: 26823752
[TBL] [Abstract] [Full Text] [Related]
15. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract] [Full Text] [Related]
16. Clinical efficacy of protein-bound polysaccharide K in patients with gastric cancer undergoing chemotherapy with an oral fluoropyrimidine (S-1).
Namikawa T; Fukudome I; Ogawa M; Munekage E; Munekage M; Shiga M; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Eur J Surg Oncol; 2015 Jun; 41(6):795-800. PubMed ID: 25887287
[TBL] [Abstract] [Full Text] [Related]
17. Incorporation of perineural invasion of gastric carcinoma into the 7th edition tumor-node-metastasis staging system.
Jiang N; Deng JY; Liu Y; Ke B; Liu HG; Liang H
Tumour Biol; 2014 Sep; 35(9):9429-36. PubMed ID: 24972970
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
[TBL] [Abstract] [Full Text] [Related]
19. Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population.
Chen S; Zheng Z; Tang J; Lin X; Wang X; Lin J
Carcinogenesis; 2013 May; 34(5):1018-24. PubMed ID: 23349019
[TBL] [Abstract] [Full Text] [Related]
20. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
[TBL] [Abstract] [Full Text] [Related]
[Next]
